TrinityPoint Wealth’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$4.05M Buy
40,710
+1,892
+5% +$195K 0.57% 41
2024
Q3
$4.41M Sell
38,818
-34,127
-47% -$4.05M 0.63% 39
2024
Q2
$9.03M Sell
72,945
-1,100
-1% -$142K 1.41% 12
2024
Q1
$9.77M Buy
74,045
+422
+0.6% +$52K 1.62% 11
2023
Q4
$8.03M Buy
73,623
+430
+0.6% +$44.6K 1.45% 14
2023
Q3
$7.54M Buy
73,193
+2,148
+3% +$232K 1.5% 12
2023
Q2
$8.2M Buy
71,045
+164
+0.2% +$18.6K 1.6% 10
2023
Q1
$7.54M Sell
70,881
-993
-1% -$107K 1.62% 12
2022
Q4
$7.97M Sell
71,874
-724
-1% -$74K 1.82% 10
2022
Q3
$6.25M Buy
72,598
+16,716
+30% +$1.49M 1.43% 14
2022
Q2
$5.09M Buy
55,882
+813
+1% +$72.1K 1.13% 20
2022
Q1
$4.52M Sell
55,069
-509
-0.9% -$40.1K 0.82% 28
2021
Q4
$4.26M Buy
55,578
+36,901
+198% +$2.94M 0.76% 33
2021
Q3
$1.4M Buy
18,677
+2,054
+12% +$156K 0.27% 84
2021
Q2
$1.29M Sell
16,623
-1,533
-8% -$114K 0.26% 88
2021
Q1
$1.34M Buy
18,156
+288
+2% +$21.2K 0.31% 78
2020
Q4
$1.37M Buy
17,868
+117
+0.7% +$8.95K 0.33% 77
2020
Q3
$1.41M Buy
17,751
+108
+0.6% +$8.46K 0.39% 67
2020
Q2
$1.3M Sell
17,643
-7
-0% -$527 0.41% 67
2020
Q1
$1.3M Buy
17,650
+1,925
+12% +$151K 0.51% 49
2019
Q4
$1.36M Buy
15,725
+215
+1% +$17.7K 0.46% 57
2019
Q3
$1.24M Buy
15,510
+2,947
+23% +$236K 0.43% 62
2019
Q2
$980K Buy
12,563
+261
+2% +$20K 0.47% 55
2019
Q1
$976K Buy
12,302
+1,553
+14% +$116K 0.48% 59
2018
Q4
$784K Buy
+10,749
New +$759K 0.48% 63

Other funds holding MRK

TrinityPoint Wealth's MRK Position: Q4 2024 in Review

TrinityPoint Wealth increased its Merck (MRK) stake by 4.9% in Q4 2024, buying an estimated $195K and bringing the position to 40,710 shares worth $4.05M. The position accounts for 0.57% of the portfolio, ranked #41.

TrinityPoint Wealth first reported a position in MRK in Q4 2018 and has held it in 25 quarters since. The position peaked at $9.77M in Q1 2024. 3,607 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

  • TrinityPoint Wealth held 40,710 shares of Merck worth $4.05M as of Q4 2024.
  • TrinityPoint Wealth bought 1,892 Merck shares in Q4 2024, an estimated $195K.
  • Merck made up 0.57% of TrinityPoint Wealth's portfolio in Q4 2024, its #41 holding.
  • TrinityPoint Wealth first reported a position in Merck in Q4 2018 and has held it in 25 quarters since.
  • TrinityPoint Wealth's Merck position peaked at $9.77M in Q1 2024.
  • 3,607 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on TrinityPoint Wealth's 13F filing for Q4 2024, filed 14 Feb 2025.